(Q37575613)

21 August 2017

1 reference

title

Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma (English)

1 reference

21 August 2017

0 references

0 references

1 reference

Mhairi A Morris

1

1 reference

21 August 2017

Christopher W Dawson

series ordinal

2

1 reference

21 August 2017

Lawrence S Young

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

6

1 reference

21 August 2017

811-825

1 reference

Epstein-Barr virus: 40 years on

21 August 2017

1 reference

Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese

21 January 2018

1 reference

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

21 January 2018

1 reference

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

21 January 2018

1 reference

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.

21 January 2018

1 reference

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

21 January 2018

1 reference

EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas

21 January 2018

1 reference

Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

21 January 2018

1 reference

Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1.

21 January 2018

1 reference

Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells.

21 January 2018

1 reference

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

21 January 2018

1 reference

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

LMP1 structure and signal transduction

21 January 2018

1 reference

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

21 January 2018

1 reference

Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue

21 January 2018

1 reference

Modulation of LMP1 protein expression by EBV-encoded microRNAs

21 January 2018

1 reference

LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling

21 January 2018

1 reference

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

21 January 2018

1 reference

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.

21 January 2018

1 reference

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

21 January 2018

1 reference

Negative regulation of Epstein-Barr virus latent membrane protein 1-mediated functions by the bone morphogenetic protein receptor IA-binding protein, BRAM1.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1: structure and functions

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling

21 January 2018

1 reference

Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway

21 January 2018

1 reference

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines

21 January 2018

1 reference

Focus on nasopharyngeal carcinoma

21 January 2018

1 reference

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments

21 January 2018

1 reference

High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

21 January 2018

1 reference

Dual regulation of the DeltaNp63 transcriptional activity by DeltaNp63 in human nasopharyngeal carcinoma cell

21 January 2018

1 reference

The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection

21 January 2018

1 reference

Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases

21 January 2018

1 reference

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells

21 January 2018

1 reference

Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes

21 January 2018

1 reference

Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells

21 January 2018

1 reference

Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells

21 January 2018

1 reference

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo

21 January 2018

1 reference

The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation

21 January 2018

1 reference

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

21 January 2018

1 reference

Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells

21 January 2018

1 reference

Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells

21 January 2018

1 reference

Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma.

21 January 2018

1 reference

Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-beta2 expression via DNA methylation

21 January 2018

1 reference

Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.

21 January 2018

1 reference

EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells

21 January 2018

1 reference

Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells

21 January 2018

1 reference

Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: possible upregulation by Epstein-Barr virus latent membrane protein 1.

21 January 2018

1 reference

Cadherins as Modulators of Cellular Phenotype

21 January 2018

1 reference

Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells

21 January 2018

1 reference

The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases

21 January 2018

1 reference

Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma

21 January 2018

1 reference

Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling

21 January 2018

1 reference

EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration.

21 January 2018

1 reference

MUC1, the renaissance molecule

21 January 2018

1 reference

Mucin glycoproteins in neoplasia

21 January 2018

1 reference

The MUC gene family: their role in diagnosis and early detection of pancreatic cancer

21 January 2018

1 reference

MUC1 and the immunobiology of cancer

21 January 2018

1 reference

MUC1 and the MUCs: a family of human mucins with impact in cancer biology

21 January 2018

1 reference

MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling

21 January 2018

1 reference

RECK is a target of Epstein–Barr virus latent membrane protein 1

21 January 2018

1 reference

Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth

21 January 2018

1 reference

Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization

21 January 2018

1 reference

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma

21 January 2018

1 reference

ECM signalling: orchestrating cell behaviour and misbehaviour.

21 January 2018

1 reference

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1

21 January 2018

1 reference

Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma

21 January 2018

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.

21 January 2018

1 reference

Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells

21 January 2018

1 reference

EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells

21 January 2018

1 reference

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha

21 January 2018

1 reference

Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line

21 January 2018

1 reference

Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma

21 January 2018

1 reference

Potential selection of LMP1 variants in nasopharyngeal carcinoma

21 January 2018

1 reference

Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia

21 January 2018

1 reference

Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma

21 January 2018

1 reference

The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity

21 January 2018

1 reference

Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.

21 January 2018

1 reference

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

21 January 2018

1 reference

Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients

21 January 2018

1 reference

The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.

21 January 2018

1 reference

Lack of cytotoxic property in a variant of Epstein–Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.09.53

1 reference

21 August 2017

1 reference